A detailed history of Geode Capital Management, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 581,958 shares of EBS stock, worth $4.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
581,958
Previous 556,182 4.63%
Holding current value
$4.49 Million
Previous $3.79 Million 28.1%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.72 - $14.77 $147,438 - $380,711
25,776 Added 4.63%
581,958 $4.86 Million
Q2 2024

Aug 09, 2024

SELL
$1.86 - $6.98 $1.05 Million - $3.94 Million
-565,013 Reduced 50.39%
556,182 $3.79 Million
Q1 2024

May 13, 2024

BUY
$1.5 - $3.41 $35,964 - $81,758
23,976 Added 2.19%
1,121,195 $2.84 Million
Q4 2023

Feb 13, 2024

BUY
$1.82 - $3.16 $142,294 - $247,061
78,184 Added 7.67%
1,097,219 $2.63 Million
Q3 2023

Nov 13, 2023

BUY
$3.17 - $7.91 $299,726 - $747,898
94,551 Added 10.23%
1,019,035 $3.46 Million
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $206,020 - $370,276
28,030 Added 3.13%
924,484 $6.79 Million
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $296,331 - $619,671
38,040 Added 4.43%
896,454 $9.29 Million
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $241,934 - $471,771
21,994 Added 2.63%
858,414 $10.1 Million
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $89,782 - $159,990
4,469 Added 0.54%
836,420 $17.6 Million
Q2 2022

Aug 12, 2022

BUY
$27.42 - $43.63 $392,215 - $624,083
14,304 Added 1.75%
831,951 $25.8 Million
Q1 2022

May 13, 2022

SELL
$36.48 - $52.22 $917,508 - $1.31 Million
-25,151 Reduced 2.98%
817,647 $33.6 Million
Q4 2021

Feb 11, 2022

BUY
$33.11 - $55.01 $653,127 - $1.09 Million
19,726 Added 2.4%
842,798 $36.6 Million
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $991,636 - $1.31 Million
-19,805 Reduced 2.35%
823,072 $41.2 Million
Q2 2021

Aug 13, 2021

BUY
$56.61 - $80.46 $1.07 Million - $1.52 Million
18,945 Added 2.3%
842,877 $53.1 Million
Q1 2021

May 12, 2021

BUY
$86.23 - $125.19 $11.6 Million - $16.8 Million
134,198 Added 19.46%
823,932 $76.6 Million
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $3.14 Million - $4.42 Million
39,673 Added 6.1%
689,734 $61.8 Million
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $377,113 - $621,263
-4,604 Reduced 0.7%
650,061 $67.2 Million
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $726,555 - $1.2 Million
13,373 Added 2.09%
654,665 $51.8 Million
Q1 2020

May 14, 2020

BUY
$49.34 - $68.76 $1.97 Million - $2.75 Million
39,965 Added 6.65%
641,292 $37.1 Million
Q4 2019

Feb 13, 2020

BUY
$51.21 - $59.06 $1.19 Million - $1.37 Million
23,197 Added 4.01%
601,327 $32.4 Million
Q3 2019

Nov 12, 2019

SELL
$40.6 - $57.2 $578,265 - $814,699
-14,243 Reduced 2.4%
578,130 $30.2 Million
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $1.95 Million - $2.63 Million
48,789 Added 8.98%
592,373 $28.6 Million
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $1.05 Million - $1.44 Million
21,768 Added 4.17%
543,584 $27.5 Million
Q4 2018

Feb 13, 2019

BUY
$55.63 - $73.24 $3 Million - $3.95 Million
53,986 Added 11.54%
521,816 $30.9 Million
Q3 2018

Nov 13, 2018

BUY
$52.05 - $66.51 $3.9 Million - $4.99 Million
74,971 Added 19.08%
467,830 $30.8 Million
Q2 2018

Aug 14, 2018

BUY
$48.33 - $55.64 $2.75 Million - $3.17 Million
56,978 Added 16.96%
392,859 $19.8 Million
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $175,715 - $215,058
3,954 Added 1.19%
335,881 $17.7 Million
Q4 2017

Feb 13, 2018

BUY
$37.77 - $47.75 $95,784 - $121,094
2,536 Added 0.77%
331,927 $15.4 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $475,638 - $563,549
13,932 Added 4.42%
329,391 $13.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
315,459
315,459 $10.7 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $385M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.